HERPESVIRUS

Clinical trials for HERPESVIRUS explained in plain language.

Never miss a new study

Get alerted when new HERPESVIRUS trials appear

Sign up with your email to follow new studies for HERPESVIRUS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

Could this vaccine stop the 'Kissing Disease' and its Long-Term risks?

⭐️ VACCINE ⭐️ Completed

This study tested a new vaccine designed to prevent Epstein-Barr virus (EBV) infection, which causes mononucleosis and is linked to certain cancers and autoimmune diseases. The trial involved 25 healthy adults aged 18 to 25 who had never had EBV. Participants received either the …

Matched conditions: HERPESVIRUS

Phase: PHASE1, PHASE2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: ⭐️ VACCINE ⭐️

Last updated May 11, 2026 20:49 UTC

HERPESVIRUS

Get alerted when new HERPESVIRUS trials appear

Could this vaccine stop the 'Kissing Disease' and its Long-Term risks?